Diagnostic utility of fusion 18F-fluorodeoxyglucose positron emission tomography/cardiac magnetic resonance imaging in cardiac sarcoidosis

• Published in: Journal of nuclear cardiology Vol. 29; no. 2; pp. 753 - 764
• Main Authors: Okune, Mana, Yasuda, Masakazu, Soejima, Naoko, Kagioka, Yoshinori, Kakehi, Kazuyoshi, Kawamura, Takayuki, Hanaoka, Kohei, Kaida, Hayato, Ishii, Kazunari, Nakazawa, Gaku, Miyazaki, Shunichi, Iwanaga, Yoshitaka
• Format: Journal Article
• Language: English
• Published: Cham Elsevier Inc 01.04.2022; Springer International Publishing; Springer Nature B.V
• Subjects: cardiac magnetic resonance; Cardiac sarcoidosis; Cardiology; fusion imaging; Imaging; Medical diagnosis; Medicine; Medicine & Public Health; Nuclear Medicine; Original Article; positron emission tomography; Radiology; Sarcoidosis; Tomography; FDG; MTMR; CMR; fusion imaging; COV; LGE; Cardiac sarcoidosis; CS; NPV; SUV; PPV; AHA; JCS; positron emission tomography; MBR; cardiac magnetic resonance; PET
• ISSN: 1071-3581; 1532-6551
• DOI: 10.1007/s12350-020-02359-y

Although each 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) and cardiac magnetic resonance (CMR) imaging with late gadolinium enhancement (LGE) has been used to diagnose cardiac sarcoidosis (CS), active CS is still misdiagnosed. Active CS, diagnosed by PET alone, was defined as focal or focal on diffuse FDG uptake pattern. In fusion PET/CMR imaging, using a regional analysis with AHA 17-segment model, the patients were categorized into four groups: (1) PET−/LGE−, (2) PET+/LGE−, (3) PET+/LGE+, and (4) PET−/LGE+. PET+/LGE+ was defined as active CS. 74 Patients with suspected CS were enrolled. Between PET alone and fusion PET/CMR imaging, 20 cases had mismatch evaluations of active CS, and most had diffuse or focal on diffuse FDG uptake pattern on PET alone imaging. 40 Patients fulfilled the 2016 the Japanese Circulation Society diagnostic criteria for CS. The interobserver diagnostic agreement was excellent (κ statistics 0.89) and the overall accuracy for diagnosing CS was 87.8% in fusion PET/CMR imaging, which were superior to those in PET alone imaging (0.57 and 82.4%, respectively). In a sub-analysis of diffuse and focal on diffuse patterns, the agreement (κ statistics 0.86) and overall accuracy (81.8%) in fusion PET/CMR imaging were still better. Fusion PET/CMR imaging with regional analysis offered reliable and accurate diagnosis of CS, covering low diagnostic area by FDG-PET alone.